GAMALATE B6 ORAL SOLUTION

Indications

• Cognitive enhancement
• Neuroprotective strategies in neurodegenerative diseases
• Potential roles in mood disorders

Dosage

Children: Refer to BNF for Children for specific dosing information.

Adults: Refer to BNF for specific dosing information.

Mechanism of action

Glutamate activates both ionotropic (AMPA, kainate, and NMDA receptors) and metabotropic glutamate receptors. It is primarily involved in neuronal signaling and synaptic transmission. Due to its inability to cross the blood-brain barrier, it is converted into L-glutamine for utilization in the brain.

Pharmacodynamics

As an excitatory neurotransmitter, glutamate is essential for normal brain function. It is a key player in neurotransmission and synaptic plasticity, influencing learning and memory. Moreover, it acts as a precursor for GABA synthesis in GABAergic neurons.

Pharmacokinetics

Glutamate is not freely available in significant quantities in the brain due to the blood-brain barrier. Instead, it is synthesized from glucose and other precursors. Its metabolism involves conversion into L-glutamine, which is then utilized in the brain. The transient nature of glutamate makes it challenging to study pharmacokinetically.

Pregnancy

Glutamate is generally regarded as safe during pregnancy when consumed in normal dietary amounts, but excessive intake, particularly in supplement form, should be approached with caution.

Breast-feeding

Glutamate is considered safe during breastfeeding as it is naturally present in various foods and is not expected to pose a risk to nursing infants.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Respiratory conditions (e.g., asthma, chronic obstructive pulmonary disease)
• Cough (e.g., as an antitussive)
• Anxiety and sleep disorders (when associated with specific formulations)

Dosage

Children: Refer to the BNF for Children for appropriate dosing information, as it is determined based on weight and age for the specific formulation.

Adults: Refer to the specific product monograph for dosing information, as it varies based on the drug formulation and indication.

Mechanism of action

Hydrobromides often act as competitive antagonists or agonists at specific receptor sites, depending on the drug involved. The exact mechanism can vary widely, but many hydrobromide-containing drugs modulate neurotransmitter activity, impacting various pathways in the body such as those involved in the central nervous system or respiratory function. The metabolic pathways include Phase I reactions primarily mediated by cytochrome P450 enzymes, which facilitate the functionalization and clearance of these compounds.

Pharmacodynamics

The pharmacodynamics of hydrobromide salts are largely determined by the specific drug they are associated with. Generally, hydrobromides may exhibit effects such as sedation, bronchodilation, or antitussive actions. The efficacy and adverse effects are influenced by the drug's receptor selectivity, affinity, and the pharmacological properties inherent to the parent compound.

Pharmacokinetics

Hydrobromides typically exhibit variable pharmacokinetic profiles depending on the specific drug formulation. They are generally absorbed rapidly following oral administration, with peak plasma concentrations occurring within a few hours. Metabolism primarily occurs in the liver through cytochrome P450 enzymes, particularly CYP2E1, among others. The elimination half-life varies but is often in the range of several hours, allowing for once or twice-daily dosing in many formulations. Excretion is usually via the kidneys, with metabolites being eliminated in urine.

Pregnancy

There are no adequate and well-controlled studies in pregnant women. Use only if clearly needed and the potential benefits justify the potential risks to the fetus.

Breast-feeding

Caution is advised; consider the importance of the drug to the mother against potential risks to the breastfeeding infant.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Mechanism of action

Glutamate activates both ionotropic and metabotropic glutamate receptors. The ionotropic ones being non-NMDA (AMPA and kainate) and NMDA receptors. Free glutamic acid cannot cross the blood-brain barrier in appreciable quantities; instead it is converted into L-glutamine, which the brain uses for fuel and protein synthesis. It is conjectured that glutamate is involved in cognitive functions like learning and memory in the brain, though excessive amounts may cause neuronal damage associated in diseases like amyotrophic lateral sclerosis, lathyrism, and Alzheimer's disease. Also, the drug phencyclidine (more commonly known as PCP) antagonizes glutamate at the NMDA receptor, causing behavior reminiscent of schizophrenia. Glutamate in action is extremely difficult to study due to its transient nature.

Pharmacodynamics

In addition to being one of the building blocks in protein synthesis, it is the most widespread neurotransmitter in brain function, as an excitatory neurotransmitter and as a precursor for the synthesis of GABA in GABAergic neurons.